Alzheon, Inc.
Framingham, MA
- UEI
- D5EMA8JZJ9C8
- CAGE
- 70HQ7
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 111 Speen St, Framingham, MA 01701, USA
- Website
- alzheon.com
- Founded
- 2013
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Randomized, double-blind, placebo-controlled, phase 3 study | National Institute on Aging (NIH) | $126,190,244 |
Quick answers
Is Alzheon, Inc. registered in SAM.gov?
Yes. Alzheon, Inc.'s SAM.gov registration is active through September 9, 2027.
What is Alzheon, Inc.'s most recent federal award?
Alzheon, Inc.'s most recent federal grant award is Randomized, double-blind, placebo-controlled, phase 3 study (R01AG065253), from National Institute on Aging (NIH), on August 15, 2020.
On GovTribe
See Alzheon, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors